Daniel R. Chevallard, CFO of Lenz Therapeutics LENZ, has filed 4 purchases and 5 sales on the open market. Over the past 12 months that comes to a net purchase of $114.3K. The latest trade was on 03/27.

DC

DC

Daniel R. Chevallard

CFO

Company

Lenz Therapeutics LENZ

First filing

23/02/28

Trades

25 trades

Buys / sales

4 / 5

12-month net buying

$114.3K

Last trade

03/27

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Lenz TherapeuticsLENZ	Open-market buy	03/27	03/30	7,500 sh	$8.57	$64,275	+139.2%
Lenz TherapeuticsLENZ	Open-market buy	25/11/07	25/11/07	2,198 sh2 trades	$22.76avg.	$50,025.48	+68.9%
Lenz TherapeuticsLENZ	Open-market buy	24/05/14	24/05/15	3,188 sh	$15.68	$49,987.84	No record
VT Viracta Therapeutics	Open-market sale	24/02/27	24/02/27	3,405 sh	$0.73	$2,485.65	−3.2%
VT Viracta Therapeutics	Open-market sale	23/11/28	23/11/28	3,720 sh	$0.50	$1,860	−3.6%
VT Viracta Therapeutics	Open-market sale	23/08/28	23/08/29	3,512 sh	$1.45	$5,092.4	−3.5%
VT Viracta Therapeutics	Open-market sale	23/05/25	23/05/26	3,635 sh	$1.42	$5,161.7	−3.8%
VT Viracta Therapeutics	Open-market sale	23/02/27	23/02/28	3,599 sh	$1.68	$6,046.32	−3.9%